IMV Inc IMVIQ

RE:results

[QM45]

One of the more coherent and thoughtful posts Sandinista I have read in a while.
Don't pay attention to the drivel from Pumbuster who has never said anything coherent and probably never will and as such should be on everyone's ignore list. His IQ is equal only to his account, which I proved to be zero :) 

The results from IMV were fine. There is nothing wrong with the science based on the update. However if you try to judge the science by the price action  then they clearly do not say the same thing. 

I 100% agree that Wells Fargo a...hole screwed the stock. I was trading the stock pre market and it was gapping by a buck. I sold a few thousand shares at 530-550US. Only when Wells downgraded the stock the avalanche of orders came through to the sell side and cratered the stock. His initial stock price made no sense, his upgrade few weeks later made no sense and this makes even less sense. What game is he playing is anyone's guess, but it's not in IMV's interest. 

His reasoning that it's hard to isolate DPX from low dose cyclophosphamide is loughable. Just read the last 5 years of  DPX data moron, not to mention all these patients were so heavily chemo pretreated that no amount of chemo could have an effect on them. That's why it's called platinum resistance.  This guy is so out of line from the other analysts it's not even funny... 

Last two days cost me on paper 250K+, I am not happy about it, but at the same time it matters little to me as a registration trial and FDA approval are clearly in sight based on this data set. I was never in this for a buck or two, but for a much larger payout. 

I am keen to hear what Dorigo has to say tommorow. Unlike the Wells Fargo goofball, this guy is a real leading cancer scientist who is also a lead in this trial. He is THERE on the front line with these patients. What he thinks about DPX is of far greater significance to me than some Wall Street a..hole trying to game the stock.